Kadcyla
Kadcyla 160mg 1 Vial (Refrigerated)
E£ 86.370,00
Quantity
1
Free delivery over 300 EGP · 24hr express in Cairo
100% authentic — licensed Egyptian pharmacy
14-day return on unopened items
Trastuzumab emtansine IV vial for HER2-positive breast cancer treatment.
Active Ingredient: Ado-Trastuzumab Emtansine Breast cancer, metastatic: Treatment (single-agent) of HER2-positive, metastatic breast cancer in patients who previously received trastuzumab and a taxane, separately or in combination, and have either received prior therapy for metastatic disease or developed disease recurrence during or within 6 months of completing adjuvant therapy.
BUNDLE & SAVE
Frequently bought together
PAIRS WELL WITH
Complete the routine
YOU MAY ALSO LIKE
Related products
CONTINUE BROWSING